- Home
- LRE vs HKPD Comparison
LRE vs HKPD Comparison
Compare LRE & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRE
- HKPD
- Stock Information
- Founded
- LRE 2001
- HKPD 2016
- Country
- LRE Japan
- HKPD Hong Kong
- Employees
- LRE N/A
- HKPD N/A
- Industry
- LRE
- HKPD Other Pharmaceuticals
- Sector
- LRE
- HKPD Health Care
- Exchange
- LRE Nasdaq
- HKPD Nasdaq
- Market Cap
- LRE 18.3M
- HKPD 15.9M
- IPO Year
- LRE 2023
- HKPD 2025
- Fundamental
- Price
- LRE $1.25
- HKPD $1.20
- Analyst Decision
- LRE
- HKPD
- Analyst Count
- LRE 0
- HKPD 0
- Target Price
- LRE N/A
- HKPD N/A
- AVG Volume (30 Days)
- LRE 2.6K
- HKPD 96.0K
- Earning Date
- LRE 01-01-0001
- HKPD 01-01-0001
- Dividend Yield
- LRE N/A
- HKPD N/A
- EPS Growth
- LRE N/A
- HKPD N/A
- EPS
- LRE 0.29
- HKPD 0.21
- Revenue
- LRE $117,804,154.00
- HKPD $20,770,344.00
- Revenue This Year
- LRE N/A
- HKPD N/A
- Revenue Next Year
- LRE N/A
- HKPD N/A
- P/E Ratio
- LRE $4.20
- HKPD $5.20
- Revenue Growth
- LRE 8.82
- HKPD 32.91
- 52 Week Low
- LRE $1.10
- HKPD $1.04
- 52 Week High
- LRE $13.76
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- LRE 50.02
- HKPD N/A
- Support Level
- LRE $1.19
- HKPD N/A
- Resistance Level
- LRE $1.26
- HKPD N/A
- Average True Range (ATR)
- LRE 0.04
- HKPD 0.00
- MACD
- LRE 0.03
- HKPD 0.00
- Stochastic Oscillator
- LRE 82.37
- HKPD 0.00
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.